GleamWall
中文EN

BAX BAXTER INTERNATIONAL INC

Surgical & Medical Instruments & Apparatus · NYSE · SEC CIK 10456 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY5.3%
TTM net income YoY-112.0%
TTM EPS YoY-115.2%
Revenue 3-yr CAGR0.7%
Net income 3-yr CAGR—

Margins

Gross margin30.1%
Operating margin-1.9%
Net margin-6.2%
FCF margin—
EBITDA margin3.8%

Returns

ROE-10.5%
ROA-3.6%
ROIC (approx.)-3.5%
Asset turnover0.57x

Leverage & solvency

Liabilities / assets66.6%
Debt / equity0.00x
Current ratio1.79x
Interest coverage-0.75x

Cash quality & payout

Operating cash flow / net income-2.27x
Accruals ratio-11.7%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$11.24B$10.64B
Cost of revenue$7.87B$6.65B
Gross profit$3.38B$3.98B
R&D expense$518.00M$590.00M
SG&A expense$2.89B$2.97B
Operating income-$308.00M$14.00M
Interest expense$290.00M$408.00M
Pretax income-$505.00M-$289.00M
Income tax$395.00M$37.00M
Net income-$957.00M-$649.00M
EBITDA$673.00M$1.01B
EPS (basic)-1.87-1.27
EPS (diluted)-1.87-1.27
Dividends declared per share0.521.04
Weighted avg. shares (diluted)513.00M510.00M
Balance sheet
Cash & equivalents$1.97B$1.76B
Receivables$1.86B$1.68B
Inventory$2.23B$2.05B
Current assets$6.87B$8.85B
PP&E, net$2.91B$2.87B
Goodwill$4.93B$5.28B
Intangibles$4.37B$5.22B
Total assets$20.05B$25.78B
Current liabilities$2.97B$6.51B
Short-term debt$1.00M$2.13B
Long-term debt$9.47B$10.37B
Total debt$9.47B$12.50B
Total liabilities$13.95B$18.76B
Shareholders' equity$6.13B$6.96B
Net debt$7.51B$10.74B
Cash flow statement
Operating cash flow$845.00M$1.02B
Capital expenditure$513.00M$446.00M
Free cash flow$332.00M$573.00M
Investing cash flow$2.84B-$626.00M
Financing cash flow-$4.22B-$1.08B
Depreciation & amortization$981.00M$997.00M
Stock-based compensation$117.00M$114.00M
Dividends paid$348.00M$590.00M
Share buybacks—$0

Free plan shows the latest 2 periods; Pro shows all 19 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.